StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the software maker’s stock.
Veradigm Trading Up 0.7 %
MDRX opened at $10.51 on Friday. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $12.66. The firm’s fifty day moving average price is $9.65 and its two-hundred day moving average price is $9.39.
Hedge Funds Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC acquired a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What Are Some of the Best Large-Cap Stocks to Buy?
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Stock Splits, Do They Really Impact Investors?
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
